Ellie L. Mikes - Mar 1, 2023 Form 4 Insider Report for FREEPORT-MCMORAN INC (FCX)

Signature
Kelly C. Simoneaux on behalf of Ellie L. Mikes pursuant to a power of attorney
Stock symbol
FCX
Transactions as of
Mar 1, 2023
Transactions value $
-$386,336
Form type
4
Date filed
3/2/2023, 04:31 PM
Previous filing
Feb 16, 2023
Next filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FCX Common Stock Options Exercise $80.3K +6.67K +18.51% $12.04 42.7K Mar 1, 2023 Direct
transaction FCX Common Stock Options Exercise $37.5K +1.33K +3.12% $28.14 44K Mar 1, 2023 Direct
transaction FCX Common Stock Sale -$345K -8K -18.18% $43.16 36K Mar 1, 2023 Direct F1
transaction FCX Common Stock Sale -$159K -3.68K -10.21% $43.19 32.3K Mar 1, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FCX Options (Right to Buy) Options Exercise $0 -6.67K -100% $0.00* 0 Mar 1, 2023 Common Stock 6.67K $12.04 Direct F4
transaction FCX Options (Right to Buy( Options Exercise $0 -1.33K -50% $0.00 1.33K Mar 1, 2023 Common Stock 1.33K $28.14 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $43.1550 - $43.1650. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2 The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $43.1650 - $43.2650. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Amount beneficially owned includes 29,333 Common Stock Restricted Stock Units.
F4 Options granted were 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof.